SCHEMBL12469779

SCHEMBL12469779

Fc1nc(F)c(-c2ccccc2)c(N2CCNCC2)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 3/20 0.44
HRH4 Q9H3N8 1/20 0.43
HTR1A P08908 4/20 0.43
HTR7 P34969 3/20 0.43
HTR6 P50406 3/20 0.43
HTR2A P28223 1/20 0.43
HTR5A P47898 1/20 0.43
PRKCI P41743 2/20 0.43
ALDH1A1 P00352 1/20 0.43
HPGD P15428 1/20 0.43
NPY5R Q15761 1/20 0.42
GBA1 P04062 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
ALOX15 P16050 1/20 0.42
CLK4 Q9HAZ1 1/20 0.42
HTR3E A5X5Y0 1/20 0.42
HTR3B O95264 1/20 0.42
ADRB1 P08588 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14746663 0.80 HRH4 (0.40) HTR2CHRH4HTR6PRKCIALDH1A1
SCHEMBL2754180 0.73 HRH4 (0.59) HRH4NPY5R
SCHEMBL28374925 0.73 MAPT (0.40) ALDH1A1HPGDCYP1A2CYP3A4KDM4E
SCHEMBL12936297 0.72 PDE4A (0.53) HTR2CHRH4HTR1AHTR7HTR6
SCHEMBL14746666 0.70 PTPN11 (0.57) HTR6HTR2AALDH1A1HPGDKDM4E
SCHEMBL13309721 0.70 PRKCI (0.51) HTR2CHTR1AHTR7HTR6HTR2A
SCHEMBL4043690 0.69 HRH4 (0.47) HTR2CHRH4HTR1AHTR7HTR6
SCHEMBL9047001 0.69 KDM4E (0.45) HTR2CHRH4HTR1AHTR7HTR6
SCHEMBL6529923 0.69 NPY5R (0.46) HRH4HTR6PRKCIALDH1A1HPGD
SCHEMBL13116661 0.68 ALDH1A1 (0.49) HTR2CHRH4HTR1AHTR7HTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2678334-A1 ANTI-VIRAL COMPOUNDS Abbvie Inc. (US) 2014-01-01 EP disclosed
EP-2627651-A1 ANTI-VIRAL COMPOUNDS Abbvie Inc. (US) 2013-08-21 EP disclosed
WO-2012116257-A1 ANTI-VIRAL COMPOUNDS ABBVIE INC. (US) 2012-08-30 WO disclosed
WO-2012051361-A1 ANTI-VIRAL COMPOUNDS ABBOTT LABORATORIES (US) 2012-04-19 WO disclosed